A novel approach for large-scale manufacturing of small extracellular vesicles from bone marrow-derived mesenchymal stromal cells using a hollow fiber bioreactor

Mesenchymal stromal cells (MSCs) are promising therapeutic candidates in a variety of diseases due to having immunomodulatory and pro-regenerative properties. In recent years, MSC-derived small extracellular vesicles (sEVs) have attracted increasing interest as a possible alternative to conventional...

Full description

Bibliographic Details
Main Authors: Viktoria Jakl, Melanie Ehmele, Martina Winkelmann, Simon Ehrenberg, Tim Eiseler, Benedikt Friemert, Markus Thomas Rojewski, Hubert Schrezenmeier
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2023.1107055/full
_version_ 1797944946515247104
author Viktoria Jakl
Melanie Ehmele
Martina Winkelmann
Simon Ehrenberg
Tim Eiseler
Benedikt Friemert
Markus Thomas Rojewski
Markus Thomas Rojewski
Hubert Schrezenmeier
Hubert Schrezenmeier
author_facet Viktoria Jakl
Melanie Ehmele
Martina Winkelmann
Simon Ehrenberg
Tim Eiseler
Benedikt Friemert
Markus Thomas Rojewski
Markus Thomas Rojewski
Hubert Schrezenmeier
Hubert Schrezenmeier
author_sort Viktoria Jakl
collection DOAJ
description Mesenchymal stromal cells (MSCs) are promising therapeutic candidates in a variety of diseases due to having immunomodulatory and pro-regenerative properties. In recent years, MSC-derived small extracellular vesicles (sEVs) have attracted increasing interest as a possible alternative to conventional cell therapy. However, translational processes of sEVs for clinical applications are still impeded by inconsistencies regarding isolation procedures and culture conditions. We systematically compared different methods for sEV isolation from conditioned media of ex vivo expanded bone marrow-derived MSCs and demonstrated considerable variability of quantity, purity, and characteristics of sEV preparations obtained by these methods. The combination of cross flow filtration with ultracentrifugation for sEV isolation resulted in sEVs with similar properties as compared to isolation by differential centrifugation combined with ultracentrifugation, the latter is still considered as gold standard for sEV isolation. In contrast, sEV isolation by a combination of precipitation with polyethylene glycol and ultracentrifugation as well as cross flow filtration and size exclusion chromatography resulted in sEVs with different characteristics, as shown by surface antigen expression patterns. The MSC culture requires a growth-promoting supplement, such as platelet lysate, which contains sEVs itself. We demonstrated that MSC culture with EV-depleted platelet lysate does not alter MSC characteristics, and conditioned media of such MSC cultures provide sEV preparations enriched for MSC-derived sEVs. The results from the systematic stepwise evaluation of various aspects were combined with culture of MSCs in a hollow fiber bioreactor. This resulted in a strategy using cross flow filtration with subsequent ultracentrifugation for sEV isolation. In conclusion, this workflow provides a semi-automated, efficient, large-scale-applicable, and good manufacturing practice (GMP)-grade approach for the generation of sEVs for clinical use. The use of EV-depleted platelet lysate is an option to further increase the purity of MSC-derived sEVs.
first_indexed 2024-04-10T20:47:37Z
format Article
id doaj.art-0dd0984c8c6741dfbd3819d911228179
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-04-10T20:47:37Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-0dd0984c8c6741dfbd3819d9112281792023-01-24T04:53:14ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852023-01-011110.3389/fbioe.2023.11070551107055A novel approach for large-scale manufacturing of small extracellular vesicles from bone marrow-derived mesenchymal stromal cells using a hollow fiber bioreactorViktoria Jakl0Melanie Ehmele1Martina Winkelmann2Simon Ehrenberg3Tim Eiseler4Benedikt Friemert5Markus Thomas Rojewski6Markus Thomas Rojewski7Hubert Schrezenmeier8Hubert Schrezenmeier9Institute for Transfusion Medicine, University Hospital Ulm, Ulm, GermanyInstitute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Donation Service Baden-Württemberg—Hessia and University Hospital Ulm, Ulm, GermanyInstitute for Transfusion Medicine, University Hospital Ulm, Ulm, GermanyInstitute for Transfusion Medicine, University Hospital Ulm, Ulm, GermanyClinic of Internal Medicine I, University Hospital Ulm, Ulm, GermanyClinic for Trauma Surgery and Orthopedics, Army Hospital Ulm, Ulm, GermanyInstitute for Transfusion Medicine, University Hospital Ulm, Ulm, GermanyInstitute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Donation Service Baden-Württemberg—Hessia and University Hospital Ulm, Ulm, GermanyInstitute for Transfusion Medicine, University Hospital Ulm, Ulm, GermanyInstitute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Donation Service Baden-Württemberg—Hessia and University Hospital Ulm, Ulm, GermanyMesenchymal stromal cells (MSCs) are promising therapeutic candidates in a variety of diseases due to having immunomodulatory and pro-regenerative properties. In recent years, MSC-derived small extracellular vesicles (sEVs) have attracted increasing interest as a possible alternative to conventional cell therapy. However, translational processes of sEVs for clinical applications are still impeded by inconsistencies regarding isolation procedures and culture conditions. We systematically compared different methods for sEV isolation from conditioned media of ex vivo expanded bone marrow-derived MSCs and demonstrated considerable variability of quantity, purity, and characteristics of sEV preparations obtained by these methods. The combination of cross flow filtration with ultracentrifugation for sEV isolation resulted in sEVs with similar properties as compared to isolation by differential centrifugation combined with ultracentrifugation, the latter is still considered as gold standard for sEV isolation. In contrast, sEV isolation by a combination of precipitation with polyethylene glycol and ultracentrifugation as well as cross flow filtration and size exclusion chromatography resulted in sEVs with different characteristics, as shown by surface antigen expression patterns. The MSC culture requires a growth-promoting supplement, such as platelet lysate, which contains sEVs itself. We demonstrated that MSC culture with EV-depleted platelet lysate does not alter MSC characteristics, and conditioned media of such MSC cultures provide sEV preparations enriched for MSC-derived sEVs. The results from the systematic stepwise evaluation of various aspects were combined with culture of MSCs in a hollow fiber bioreactor. This resulted in a strategy using cross flow filtration with subsequent ultracentrifugation for sEV isolation. In conclusion, this workflow provides a semi-automated, efficient, large-scale-applicable, and good manufacturing practice (GMP)-grade approach for the generation of sEVs for clinical use. The use of EV-depleted platelet lysate is an option to further increase the purity of MSC-derived sEVs.https://www.frontiersin.org/articles/10.3389/fbioe.2023.1107055/fullmesenchymal stromal cellsmesenchymal stem cellsplatelet lysatehollow fiber bioreactorexosomessmall extracellular vesicles
spellingShingle Viktoria Jakl
Melanie Ehmele
Martina Winkelmann
Simon Ehrenberg
Tim Eiseler
Benedikt Friemert
Markus Thomas Rojewski
Markus Thomas Rojewski
Hubert Schrezenmeier
Hubert Schrezenmeier
A novel approach for large-scale manufacturing of small extracellular vesicles from bone marrow-derived mesenchymal stromal cells using a hollow fiber bioreactor
Frontiers in Bioengineering and Biotechnology
mesenchymal stromal cells
mesenchymal stem cells
platelet lysate
hollow fiber bioreactor
exosomes
small extracellular vesicles
title A novel approach for large-scale manufacturing of small extracellular vesicles from bone marrow-derived mesenchymal stromal cells using a hollow fiber bioreactor
title_full A novel approach for large-scale manufacturing of small extracellular vesicles from bone marrow-derived mesenchymal stromal cells using a hollow fiber bioreactor
title_fullStr A novel approach for large-scale manufacturing of small extracellular vesicles from bone marrow-derived mesenchymal stromal cells using a hollow fiber bioreactor
title_full_unstemmed A novel approach for large-scale manufacturing of small extracellular vesicles from bone marrow-derived mesenchymal stromal cells using a hollow fiber bioreactor
title_short A novel approach for large-scale manufacturing of small extracellular vesicles from bone marrow-derived mesenchymal stromal cells using a hollow fiber bioreactor
title_sort novel approach for large scale manufacturing of small extracellular vesicles from bone marrow derived mesenchymal stromal cells using a hollow fiber bioreactor
topic mesenchymal stromal cells
mesenchymal stem cells
platelet lysate
hollow fiber bioreactor
exosomes
small extracellular vesicles
url https://www.frontiersin.org/articles/10.3389/fbioe.2023.1107055/full
work_keys_str_mv AT viktoriajakl anovelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT melanieehmele anovelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT martinawinkelmann anovelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT simonehrenberg anovelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT timeiseler anovelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT benediktfriemert anovelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT markusthomasrojewski anovelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT markusthomasrojewski anovelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT hubertschrezenmeier anovelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT hubertschrezenmeier anovelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT viktoriajakl novelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT melanieehmele novelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT martinawinkelmann novelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT simonehrenberg novelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT timeiseler novelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT benediktfriemert novelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT markusthomasrojewski novelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT markusthomasrojewski novelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT hubertschrezenmeier novelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor
AT hubertschrezenmeier novelapproachforlargescalemanufacturingofsmallextracellularvesiclesfrombonemarrowderivedmesenchymalstromalcellsusingahollowfiberbioreactor